P Tiraboschi Selected Research

P Tiraboschi Research Topics

7	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2000
3	Dementia (Dementias) 01/2020 - 09/2000
2	Cognitive Dysfunction 01/2020 - 11/2000
2	Parkinson Disease (Parkinson's Disease) 02/2005 - 01/2000
2	Amyloid Plaque 06/2004 - 04/2004
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2020
1	Parkinsonian Disorders (Parkinsonism) 01/2020
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2020
1	Ischemic Stroke 03/2010
1	Thrombosis (Thrombus) 03/2010
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 04/2004
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 09/2000
1	Lewy Body Disease (Lewy Body Dementia) 03/2000
1	Hallucinations (Hallucination) 03/2000

3	Apolipoproteins E (ApoE)IBA 06/2004 - 01/2000
3	Cholinergic Agents (Cholinergics)IBA 11/2000 - 01/2000
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Amyloid (Amyloid Fibrils)IBA 01/2020
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2020
1	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2010
1	Pergolide (Permax)FDA Link 02/2005
1	Amyloid beta-PeptidesIBA 06/2004
1	thioflavin TIBA 04/2004
1	4-phenyl-1,2,4-triazoline-3,5-dioneIBA 04/2004
1	alpha7 Nicotinic Acetylcholine ReceptorIBA 09/2000
1	ApolipoproteinsIBA 09/2000
1	alpha 1-Antichymotrypsin (alpha 1 Antichymotrypsin)IBA 09/2000
1	SynaptophysinIBA 09/2000
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 09/2000
1	Presenilin-1IBA 09/2000
1	Choline O-Acetyltransferase (Choline Acetyltransferase)IBA 09/2000
1	Antipsychotic Agents (Antipsychotics)IBA 03/2000

1	Institutionalization (Institutionalized Persons) 01/2017
1	Mechanical Thrombolysis 03/2010
1	Contraindications 03/2010